Therapeutic mechanisms of iPSC-MSC derived extracellular vesicles on dry mouth caused by Sjorgren's syndrome or radiotherapy
Therapeutic mechanisms of iPSC-MSC derived extracellular vesicles on dry mouth caused by Sjorgren's syndrome or radiotherapy
批准号:
10701307
负责人:
Ryang Hwa Lee
金额:
$35.98万
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
已结题
起止时间:
2022-09-23 至 2024-09-22
关键词:
Adverse effectsAffectAgingAnti-Inflammatory AgentsAutoimmune DiseasesAutoimmune ResponsesBiologicalBiological ProductsBone MarrowCell TherapyCellsClinicalClinical ResearchDerivation procedureDiseaseEndothelial CellsEpithelial CellsFundingGoalsHead and Neck CancerHumanImmuneImmune responseImpairmentIn VitroInfusion proceduresLaboratoriesMediatingMesenchymalMesenchymal Stem CellsNatural regenerationOrganOutcomePatientsProductionPropertyProteomicsQuality of lifeRadiationRadiation induced damageRadiation therapyReproducibilityResearchSalivarySalivary GlandsSjogren&aposs SyndromeSpleenStandardizationStromal CellsSyndromeTestingTherapeuticTherapeutic EffectTissuesTreatment EfficacyUnited States National Institutes of HealthVariantWorkXerostomiabaseclinical applicationclinical practiceextracellular vesicleshead and neck cancer patientimmunoregulationimprovedinduced pluripotent stem cellirradiationknock-downmacrophagemiRNA expression profilingmouse modelnanoparticlenoveloverexpressionparacrinepreclinical studyregenerativerestorationsaliva secretionside effectstemsuccesstissue regeneration
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Project Summary
The long lasting decrease of saliva secretion, also called dry mouth, is common in patients with Sjögren's
syndrome (an autoimmune disease affecting salivary glands) or treated with radiation therapy for head and neck
cancer. This side effect significantly impairs the quality of life and is difficult to remedy. Mesenchymal
stem/stromal cells (MSCs) are conventionally isolated from tissues and capable of inhibiting autoimmune
responses and promoting regeneration, and have shown therapeutic efficacies in both types of dry mouth.
However, there are many limitations of using tissue-derived MSCs directly for therapies including their high
variations and limited expandability. The applicant’s recent work revealed that MSCs derived from human
induced pluripotent stem cells (iMSCs) are highly standardized and can be produced at a large scale.
Extracellular vesicles (EVs) are nano-sized particles released from cells spontaneously. EVs carry bioactive
molecules similar to their originating cells, and are much safer and more feasible for clinical application compared
to their originating cells. iMSCs and their EVs showed immunosuppressive and pro-regenerative effects
comparable to the best tissue-derived MSCs. This proposal aims to determine therapeutic potentials and
mechanisms of iMSC EVs on both types of dry mouth. First, this project will determine therapeutic mechanisms
of systemically infused iMSC EVs on Sjögren's syndrome. Second, this project will determine therapeutic
mechanisms of locally infused iMSC EVs on the restoration of saliva secretion after local radiation. The success
of proposed research will provide the proof-of-concept and optimization guide of a novel and clinically feasible
therapy for both Sjögren's syndrome and dry mouth caused by radiation therapy. These outcomes will also
encourage further research on similar therapies for other autoimmune diseases or radiation damages to other
healthy organs.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Extracellular Vesicles Produced by Mesenchymal Stem Cells as Novel Therapy for Autoimmune Uveitis
-
批准号:10357942
-
项目类别:
-
资助金额:$36.01万
-
财政年份:2019
-
负责人:Ryang Hwa Lee
-
依托单位:
Extracellular Vesicles Produced by Mesenchymal Stem Cells as Novel Therapy for Autoimmune Uveitis
-
批准号:10582521
-
项目类别:
-
资助金额:$37.13万
-
财政年份:2019
-
负责人:Ryang Hwa Lee
-
依托单位:
海外基金